Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P61647
UPID:
SIA8F_HUMAN
Alternative names:
Sialyltransferase 8F; Sialyltransferase St8Sia VI
Alternative UPACC:
P61647; B0YJ97; B9EH72; Q5VZH4
Background:
Alpha-2,8-sialyltransferase 8F, also known as Sialyltransferase St8Sia VI, is an enzyme that catalyzes the transfer of sialic acid to glycan substrates. It exhibits a preference for O-glycans over N-glycans or glycolipids, with the minimal acceptor substrate being the NeuAc-alpha-2,3(6)-Gal sequence. This specificity plays a crucial role in the biosynthesis of complex carbohydrate structures.
Therapeutic significance:
Understanding the role of Alpha-2,8-sialyltransferase 8F could open doors to potential therapeutic strategies. Its involvement in the synthesis of sialoglycans, which are key components of cellular communication and molecular recognition processes, highlights its potential as a target for therapeutic intervention.